Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act
| dc.contributor.author | Craft, Sam | |
| dc.contributor.author | Dunn, Michael | |
| dc.contributor.author | Vidler, Dan | |
| dc.contributor.author | Officer, Jane | |
| dc.contributor.author | Blagbrough, Ian S | |
| dc.contributor.author | Pudney, Christopher R | |
| dc.contributor.author | Henderson, Graeme | |
| dc.contributor.author | Abouzeid, Ahmed | |
| dc.contributor.author | Dargan, Paul I | |
| dc.contributor.author | Eddleston, Michael | |
| dc.contributor.author | Cooper, Jamie | |
| dc.contributor.author | Hill, Simon L | |
| dc.contributor.author | Roper, Clair | |
| dc.contributor.author | Freeman, Tom P | |
| dc.contributor.author | Thomas, Simon H L | |
| dc.date.accessioned | 2025-11-25T15:47:01Z | |
| dc.date.issued | 2022-11 | |
| dc.description | We acknowledge with gratitude the work done by the research staff in all IONA sites and thank all the participants for allowing their data and samples to be used for this study. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 8 | |
| dc.format.extent | 1241353 | |
| dc.identifier | 306077369 | |
| dc.identifier | 6e8d5558-486d-4ce4-a872-1c6466933acd | |
| dc.identifier | 35665553 | |
| dc.identifier | 85132125411 | |
| dc.identifier.citation | Craft, S, Dunn, M, Vidler, D, Officer, J, Blagbrough, I S, Pudney, C R, Henderson, G, Abouzeid, A, Dargan, P I, Eddleston, M, Cooper, J, Hill, S L, Roper, C, Freeman, T P & Thomas, S H L 2022, 'Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act', Addiction, vol. 117, no. 11, pp. 2899-2906. https://doi.org/10.1111/add.15967 | en |
| dc.identifier.doi | 10.1111/add.15967 | |
| dc.identifier.issn | 0965-2140 | |
| dc.identifier.other | PubMedCentral: PMC9796520 | |
| dc.identifier.other | ORCID: /0000-0003-3812-7026/work/198456689 | |
| dc.identifier.uri | https://hdl.handle.net/2164/26472 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Addiction | en |
| dc.subject | NPS | en |
| dc.subject | PSA | en |
| dc.subject | Psychoactive Substances Act | en |
| dc.subject | SCRA | en |
| dc.subject | synthetic cannabinoid receptor agonists | en |
| dc.subject | time series analysis | en |
| dc.subject | toxicity | en |
| dc.subject | R Medicine (General) | en |
| dc.subject | Supplementary Information | en |
| dc.subject.lcc | R1 | en |
| dc.title | Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Craft_etal_ASSA_Trends_in_Hospital_VOR.pdf
- Size:
- 1.18 MB
- Format:
- Adobe Portable Document Format
